| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
ESSA Pharma (NASDAQ:EPIX) reported its Q2 earnings results on Tuesday, May 9, 2023 at 07:00 AM.
Here's what investors need to know about the announcement.
ESSA Pharma beat estimated earnings by 20.0%, reporting an EPS of $-0.16 versus an estimate of $-0.2.
Revenue was down $0 from the same period last year.
Last quarter the company beat on EPS by $0.13 which was followed by a 2.07% increase in the share price the next day.
Listen to the earnings announcement yourself by clicking here.
To track all earnings releases for ESSA Pharma visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: EPIX
